LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration

2024 . van Tilburg, Cornelis M. | Kilburn, Lindsay B. | Perreault, Sébastien | Schmidt, Rene | Azizi, Amedeo A. | Cruz-Martínez, Ofelia | Zápotocký, Michal | Scheinemann, Katrin | Meeteren, Antoinette Y. N. Schouten-van | Sehested, Astrid | Opocher, Enrico | Driever, Pablo Hernáiz | Avula, Shivaram | Ziegler, David S. | Capper, David | Koch, Arend | Sahm, Felix | Qiu, Jiaheng | Tsao, Li-Pen | Blackman, Samuel C. | Manley, Peter | Milde, Till | Witt, Ruth | Jones, David T. W. | Hargrave, Darren | Witt, Olaf